FDA to ban flavored e-cigs at U.S. convenience stores
The FDA announced sweeping new restrictions on flavored tobacco products, including electronic cigarettes popular among teenagers in an effort to prevent a new generation of nicotine addicts.
Eli Lilly Scraps A BACE Program For Alzheimer’s
FDA Approves Pfizer's Lorbrena For Certain Lung Cancer Patients
Teva Raises 2018 Profit Outlook, Sees Strong Migraine Drug Launch
Sanofi, Denali Partner On Small Molecule Development In Potential $1 Billion Deal
EU Approves Fifth Copy Of AbbVie's Humira
Allergan Says Offers Undervalue Business Units For Sale, Shares Fall
AstraZeneca's Diabetes Drug Farxiga Curbs Heart Failure, Kidney Risks
Amarin Plans To Seek FDA Approval For CV Indication For Fish Oil Drug
J&J's Stelara Succeeds In Chronic Bowel Disease Study
CVS, Aetna Win U.S. Approval For $69 Billion Merger
GSK Funds New Startup With Immunometabolic Focus
Endo Targets 2020 For Launch Of Cellulite Treatment
Otsuka, Lundbeck To Start Third Phase 3 Trial To Evaluate Brexpiprazole In Treatment Of Agitation In Patients With Alzheimer's Disease
AbbVie, Roche Combo Treatment Meets Main Goal Of Leukemia Study
Amgen’s Aimovig Starts Strong, Multiple Myeloma Drug Wows At Conference
Trulicity Leads Mixed Third-Quarter 2018 For Lilly, Shares Sink
Amicus Therapeutics Buys Celenex
Bayer CEO Backs Group's Diversified Structure
Sanofi, Regeneron Skin Cancer Drug Libtayo Receives FDA Approval
Gilead To Launch Generic Versions Of Hepatitis Drugs
Roche's Tecentriq Wins Fast FDA Review In Tough-To-Treat Breast Cancer
Takeda Lung Cancer Drug Alunbrig Gets European Panel Nod
FDA Approves New Indication For Gilotrif In EGFR Mutation-Positive NSCLC
Xtandi Delays Prostate Cancer Spread In Early-Stage Disease
Alexion To Obtain Syntimmune
Shire's Drug For Rare Swelling Disorder Wins European Panel Green Light
Merck's Frazier Joins Growing List Of Pharma CEOs Attacking Drug Rebates
Novartis plans for 60 regulatory filings during 2019-2021
BMS’ Empliciti Garners New FDA Indication For Multiple Myeloma
Novo Nordisk Hires AstraZeneca Executive To Revive Struggling Biopharma Unit
Ad Right Top
Latest News
Jury clears J&J of liability in California talc cancer case
A California jury cleared J&J of liability in a case involving a woman who alleged that the company’s talc-based products – including its baby powder – contain asbestos and caused her cancer.
REALITYRx Communication Hires New SVP, Management Supervisor
REALITYRx Communication announced that Scott Greisler joined the agency in the role of SVP, Management Supervisor.
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
October 2018 Focus: Top 50 Pharma, Company of the Year and more!